This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawai, H.
Right arrow Articles by Yuan, Z.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawai, H.
Right arrow Articles by Yuan, Z.-M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2003, p. 4939-4947, Vol. 23, No. 14
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.14.4939-4947.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Critical Contribution of the MDM2 Acidic Domain to p53 Ubiquitination

Hidehiko Kawai, Dmitri Wiederschain, and Zhi-Min Yuan*

Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115

Received 3 December 2002/ Returned for modification 22 January 2003/ Accepted 9 April 2003

MDM2 is an E3 ubiquitin ligase that targets p53 for proteasomal degradation. Recent studies have shown, however, that the ring-finger domain (RFD) of MDM2, where the ubiquitin E3 ligase activity resides, is necessary but not sufficient for p53 ubiquitination, suggesting that an additional activity of MDM2 might be required. To test this possibility, we generated a series of MDM2/MDMX chimeric proteins to assess the contribution of each domain of MDM2 to the ubiquitination process. MDMX is a close structural homolog of MDM2 that nevertheless lacks the E3 ligase activity in vivo. We demonstrate here that MDMX gains self-ubiquitination activity and becomes extremely unstable upon introduction of the MDM2 RFD, indicating that the RFD is essential for self-ubiquitination. This MDMX chimeric protein, however, is unable to ubiquitinate p53 in vivo despite its E3 ligase activity and binding to p53, separating the self-ubiquitination activity of MDM2 from its ability to ubiquitinate p53. Significantly, fusion of the central acidic domain (AD) of MDM2 to the MDMX chimeric protein renders the protein fully capable of ubiquitinating p53, and p53 ubiquitination is associated with p53 degradation and nuclear export. Moreover, the AD mini protein expressed in trans can functionally rescue the AD-lacking MDM2 mutant, further supporting a critical role for the AD in MDM2-mediated p53 ubiquitination.

* Corresponding author. Mailing address: Department of Cancer Cell Biology (Bldg. 1, Room 507), Harvard School of Public Health, 665 Huntington Ave., Boston, MA 02115. Phone: (617) 432-0763. Fax: (617) 432-0377. E-mail: zyuan{at}hsph.harvard.edu.

Molecular and Cellular Biology, July 2003, p. 4939-4947, Vol. 23, No. 14
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.14.4939-4947.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Saha, A., Murakami, M., Kumar, P., Bajaj, B., Sims, K., Robertson, E. S. (2009). Epstein-Barr Virus Nuclear Antigen 3C Augments Mdm2-Mediated p53 Ubiquitination and Degradation by Deubiquitinating Mdm2. J. Virol. 83: 4652-4669 [Abstract] [Full Text]  
  • Dai, M.-S., Sun, X.-X., Lu, H. (2008). Aberrant Expression of Nucleostemin Activates p53 and Induces Cell Cycle Arrest via Inhibition of MDM2. Mol. Cell. Biol. 28: 4365-4376 [Abstract] [Full Text]  
  • Lopez-Pajares, V., Kim, M. M., Yuan, Z.-M. (2008). Phosphorylation of MDMX Mediated by Akt Leads to Stabilization and Induces 14-3-3 Binding. J. Biol. Chem. 283: 13707-13713 [Abstract] [Full Text]  
  • Kannemeier, C., Liao, R., Sun, P. (2007). The RING Finger Domain of MDM2 Is Essential for MDM2-mediated TGF-beta Resistance. Mol. Biol. Cell 18: 2367-2377 [Abstract] [Full Text]  
  • Kulikov, R., Winter, M., Blattner, C. (2006). Binding of p53 to the Central Domain of Mdm2 Is Regulated by Phosphorylation. J. Biol. Chem. 281: 28575-28583 [Abstract] [Full Text]  
  • Jeong, M.-H., Bae, J., Kim, W.-H., Yoo, S.-M., Kim, J.-W., Song, P. I., Choi, K.-H. (2006). p19ras Interacts with and Activates p73 by Involving the MDM2 Protein. J. Biol. Chem. 281: 8707-8715 [Abstract] [Full Text]  
  • Yu, G. W., Rudiger, S., Veprintsev, D., Freund, S., Fernandez-Fernandez, M. R., Fersht, A. R. (2006). The central region of HDM2 provides a second binding site for p53. Proc. Natl. Acad. Sci. USA 103: 1227-1232 [Abstract] [Full Text]  
  • Brady, M., Vlatkovic, N., Boyd, M. T. (2005). Regulation of p53 and MDM2 Activity by MTBP. Mol. Cell. Biol. 25: 545-553 [Abstract] [Full Text]  
  • Sdek, P., Ying, H., Zheng, H., Margulis, A., Tang, X., Tian, K., Xiao, Z.-X. J. (2004). The Central Acidic Domain of MDM2 Is Critical in Inhibition of Retinoblastoma-mediated Suppression of E2F and Cell Growth. J. Biol. Chem. 279: 53317-53322 [Abstract] [Full Text]  
  • Dai, M.-S., Lu, H. (2004). Inhibition of MDM2-mediated p53 Ubiquitination and Degradation by Ribosomal Protein L5. J. Biol. Chem. 279: 44475-44482 [Abstract] [Full Text]  
  • Yoshitake, Y., Nakatsura, T., Monji, M., Senju, S., Matsuyoshi, H., Tsukamoto, H., Hosaka, S., Komori, H., Fukuma, D., Ikuta, Y., Katagiri, T., Furukawa, Y., Ito, H., Shinohara, M., Nakamura, Y., Nishimura, Y. (2004). Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray Analysis. Clin. Cancer Res. 10: 6437-6448 [Abstract] [Full Text]  
  • Kawai, H., Wiederschain, D., Kitao, H., Stuart, J., Tsai, K. K. C., Yuan, Z.-M. (2003). DNA Damage-induced MDMX Degradation Is Mediated by MDM2. J. Biol. Chem. 278: 45946-45953 [Abstract] [Full Text]  
  • de Graaf, P., Little, N. A., Ramos, Y. F. M., Meulmeester, E., Letteboer, S. J. F., Jochemsen, A. G. (2003). Hdmx Protein Stability Is Regulated by the Ubiquitin Ligase Activity of Mdm2. J. Biol. Chem. 278: 38315-38324 [Abstract] [Full Text]  
  • Meulmeester, E., Frenk, R., Stad, R., de Graaf, P., Marine, J.-C., Vousden, K. H., Jochemsen, A. G. (2003). Critical Role for a Central Part of Mdm2 in the Ubiquitylation of p53. Mol. Cell. Biol. 23: 4929-4938 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»